PATENT CLAIM ANALYSIS

Application Number: 16297410
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "458000"]

Abstract:
The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.

Claim (Index 5):
The dosage form of  claim 1 , wherein after administration of a single dose under fasting conditions to a patient in need thereof, the average C max  is about 80% to about 125% of about 10-20 ng/ml per mg of doxycycline base administered.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.25806
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14973149', '14939936', '14521998', '15359292', '10819620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8119541840024141
- 35 USC 102 Novelty (BERT): 0.6204788202684889
- Combined Prediction Score: 0.7928066476290216
- Mean Citation Score: 455.51424
- Max Citation Score: 599.9433
- Similarity Product: 530.3009960927725

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test